3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
3
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Other hematologic neoplasm
1
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
2
Neoplasms
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Oxaliplatin
197
Bevacizumab
163
Fluorouracil
155
Capecitabine
137
Gemcitabine
133
Leucovorin
112
pembrolizumab
100
Cisplatin
94
Drug Therapy
89
Irinotecan
81
Radiotherapy
73
sintilimab
70
durvalumab
65
Paclitaxel
64
130-nm albumin-bound paclitaxel
64
Specimen Handling
62
Cetuximab
61
lenvatinib
60
tislelizumab
58
Nivolumab
56
Magnetic Resonance Spectroscopy
55
Folfox protocol
55
Blood Specimen Collection
52
atezolizumab
48
Biopsy
46
Surgical Procedures, Operative
40
Immune Checkpoint Inhibitors
38
Taxes
37
Albumin-Bound Paclitaxel
37
HMPL-013
36
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Glutamyl Aminopeptidase
×
Gastrointestinal
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled
NCT05713994
2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
300 enrolled
NCT05717738
2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
300 enrolled